Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wasmuth

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 13, 2006
[Elevated concentrations of fecal calprotectin in patients with liver cirrhosis]E Yagmur, B Schnyder, D Scholten, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infectionMarie-Luise Berres, Christian Trautwein, Maximilian Schmeding, et al.
Gut|August 8, 2006
Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 geneH E Wasmuth, A Glantz, H Keppeler, et al.
Gut|April 15, 2008
Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitisN Beraza, Y Malato, S Vander Borght, et al.
Hepatology (Baltimore, Md.)|September 16, 2004
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis CHermann E Wasmuth, Alexa Werth, Tobias Mueller, et al.
Gastroenterology|February 12, 2009
c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in miceArne Giebeler, Mark V Boekschoten, Christian Klein, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2008
Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosisMarie-Luise Berres, Barbara Schnyder, Eray Yagmur, et al.
International Journal of Clinical and Experimental Pathology|September 11, 2010
Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammationGeorgi Kirovski, Erwin Gäbele, Christoph Dorn, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 21, 2012
The chemokine receptor CXCR3 limits injury after acute toxic liver damageMirko Moreno Zaldivar, Marie-Luise Berres, Hacer Sahin, et al.
Antiviral Therapy|August 16, 2012
Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapyFlorian van Bömmel, Jörg Trojan, Katja Deterding, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Deutsche Medizinische Wochenschrift (1946)|September 13, 2006
[Elevated concentrations of fecal calprotectin in patients with liver cirrhosis]E Yagmur, B Schnyder, D Scholten, et al.
Hepatology (Baltimore, Md.)|January 29, 2011
Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infectionMarie-Luise Berres, Christian Trautwein, Maximilian Schmeding, et al.
Gut|August 8, 2006
Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 geneH E Wasmuth, A Glantz, H Keppeler, et al.
Gut|April 15, 2008
Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitisN Beraza, Y Malato, S Vander Borght, et al.
Hepatology (Baltimore, Md.)|September 16, 2004
Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis CHermann E Wasmuth, Alexa Werth, Tobias Mueller, et al.
Gastroenterology|February 12, 2009
c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in miceArne Giebeler, Mark V Boekschoten, Christian Klein, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2008
Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosisMarie-Luise Berres, Barbara Schnyder, Eray Yagmur, et al.
International Journal of Clinical and Experimental Pathology|September 11, 2010
Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammationGeorgi Kirovski, Erwin Gäbele, Christoph Dorn, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 21, 2012
The chemokine receptor CXCR3 limits injury after acute toxic liver damageMirko Moreno Zaldivar, Marie-Luise Berres, Hacer Sahin, et al.
Antiviral Therapy|August 16, 2012
Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapyFlorian van Bömmel, Jörg Trojan, Katja Deterding, et al.
Pageof 11